# Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer

> **NCT03585062** · PHASE2 · TERMINATED · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Pancreatic Cancer
- Neoadjuvant Chemotherapy

## Interventions

- **DRUG:** S1,
- **DRUG:** Paclitaxel-albumin

## Key facts

- **NCT ID:** NCT03585062
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-20
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** The paclitaxel-albumin halt production.
- **Last updated:** 2021-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03585062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03585062, "Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03585062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*